Thrombosis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Thrombosis stocks.

Thrombosis Stocks Recent News

Date Stock Title
Nov 23 JNJ Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
Nov 22 JNJ Layoffs in 2024: A List of Companies Cutting Jobs This Year
Nov 22 SNY Sanofi plans to change hospital drug-discount program
Nov 22 JNJ J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
Nov 22 JNJ Medtronic acquires Fortimedix Surgical to boost surgical portfolio
Nov 22 SNY Sanofi becomes latest drugmaker to challenge HHS over 340B drug-discount program
Nov 22 JNJ Sanofi Plans to Change Hospital Drug-Discount Program
Nov 22 JNJ Health Canada issues NOC to J&J’s CARVYKTI for multiple myeloma
Nov 22 JNJ Johnson & Johnson seeks FDA approval for its ulcerative colitis treatment
Nov 22 JNJ Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and others
Nov 22 JNJ Johnson & Johnson seeks U.S. FDA approval for subcutaneous induction regimen of TREMFYA® (guselkumab) in ulcerative colitis, a first for an IL-23 inhibitor
Nov 22 JNJ Johnson & Johnson (NYSE:JNJ) Stock Goes Ex-Dividend In Just Three Days
Nov 21 JNJ Health Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy
Nov 20 SNY CDC warns of an imminent spike in COVID, flu cases
Nov 20 JNJ Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China
Nov 20 SNY Here’s What Drove Sanofi’s (SNY) Earnings
Nov 20 SNY Sanofi: Information concerning the total number of voting rights and shares - October 2024
Nov 19 JNJ Large caps in trouble? Key takeaways from Tommy Tuberville's latest trades
Nov 19 JNJ Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive
Nov 19 JNJ Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting
Thrombosis

Thrombosis (from Ancient Greek θρόμβωσις thrómbōsis "clotting”) is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. When a blood vessel (a vein or an artery) is injured, the body uses platelets (thrombocytes) and fibrin to form a blood clot to prevent blood loss. Even when a blood vessel is not injured, blood clots may form in the body under certain conditions. A clot, or a piece of the clot, that breaks free and begins to travel around the body is known as an embolus.Thrombosis may occur in veins (venous thrombosis) or in arteries. Venous thrombosis leads to congestion of the affected part of the body, while arterial thrombosis (and rarely severe venous thrombosis) affects the blood supply and leads to damage of the tissue supplied by that artery (ischemia and necrosis). A piece of either an arterial or a venous thrombus can break off as an embolus which can travel through the circulation and lodge somewhere else as an embolism. This type of embolism is known as a thromboembolism. Complications can arise when a venous thromboembolism (commonly called a VTE) lodges in the lung as a pulmonary embolism. An arterial embolus may travel further down the affected blood vessel where it can lodge as an embolism.

Browse All Tags